{"altmetric_id":1066793,"counts":{"readers":{"mendeley":13,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":1,"unique_users":["194714477275831"],"posts_count":1},"total":{"posts_count":4},"twitter":{"unique_users_count":2,"unique_users":["Oncolytics","donobo"],"posts_count":3}},"selected_quotes":["New publication in the journal Expert Opinion on Biological Therapy authored by Kyula at al.","New publication New Publication in the journal Expert Opinion on Biological Therapy authored by Kyula et al."],"citation":{"abstract":"Locally advanced head and neck cancer carries a poor prognosis, even with standard combination (surgery, radiotherapy, chemotherapy) treatment regimens. There is a pressing need for novel therapies with activity against this tumour type. Oncolytic reovirus type 3 (Dearing) is preferentially cytotoxic in tumour cells with an activated Ras signalling pathway and represents a promising novel therapy with relevance in head and neck cancer.","abstract_source":"pubmed","altmetric_jid":"4f6fa6173cf058f6100073bf","authors":["Joan N Kyula","Victoria Roulstone","Eleni M Karapanagiotou","Alan A Melcher","Kevin J Harrington"],"doi":"10.1517\/14712598.2012.745507","endpage":"1678","first_seen_on":"2012-11-14T15:53:36+00:00","funders":["cruk"],"issns":["1471-2598","1744-7682"],"issue":"12","journal":"Expert Opinion on Biological Therapy","last_mentioned_on":1352918568,"links":["http:\/\/informahealthcare.com\/doi\/abs\/10.1517\/14712598.2012.745507"],"pmid":"23140488","pubdate":"2012-12-01T00:00:00+00:00","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"}],"scopus_subjects":["Life Sciences","Pharmacology, Toxicology and Pharmaceutics","Biochemistry, Genetics and Molecular Biology"],"startpage":"1669","subjects":["biology"],"title":"Oncolytic reovirus type 3 (Dearing) as a novel therapy in head and neck cancer.","type":"article","volume":"12","mendeley_url":"http:\/\/www.mendeley.com\/research\/oncolytic-reovirus-type-3-dearing-novel-therapy-head-neck-cancer-2"},"altmetric_score":{"score":2.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":2.25},"context_for_score":{"all":{"total_number_of_other_articles":4507280,"mean":5.1336924524522,"rank":1713281,"this_scored_higher_than_pct":61,"this_scored_higher_than":2756581,"rank_type":"exact","sample_size":4507280,"percentile":61},"similar_age_3m":{"total_number_of_other_articles":79895,"mean":5.4232161363808,"rank":24692,"this_scored_higher_than_pct":68,"this_scored_higher_than":54396,"rank_type":"exact","sample_size":79895,"percentile":68},"this_journal":{"total_number_of_other_articles":673,"mean":2.0500952380952,"rank":176,"this_scored_higher_than_pct":73,"this_scored_higher_than":497,"rank_type":"exact","sample_size":673,"percentile":73},"similar_age_this_journal_3m":{"total_number_of_other_articles":21,"mean":1.115,"rank":2,"this_scored_higher_than_pct":90,"this_scored_higher_than":19,"rank_type":"exact","sample_size":21,"percentile":90}}},"demographics":{"poster_types":{"member_of_the_public":1,"practitioner":1},"users":{"twitter":{"cohorts":{"Members of the public":2}},"mendeley":{"by_status":{"Researcher":3,"Student  > Doctoral Student":1,"Student  > Ph. D. Student":2,"Student  > Master":2,"Student  > Bachelor":5},"by_discipline":{"Medicine and Dentistry":2,"Chemistry":1,"Immunology and Microbiology":1,"Psychology":2,"Agricultural and Biological Sciences":4,"Biochemistry, Genetics and Molecular Biology":2,"Environmental Science":1}}},"geo":{"twitter":{"CA":1}}},"posts":{"facebook":[{"title":"Oncolytic reovirus type 3 (Dearing) as... [Expert Opin Biol Ther. 2012] - PubMed - NCBI","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=439509226109260&id=194714477275831","license":"public","citation_ids":[1066793],"posted_on":"2012-11-14T15:57:17+00:00","summary":"New publication in the journal Expert Opinion on Biological Therapy authored by Kyula at al. titled \"Oncolytic reovirus type 3 (Dearing) as a novel therapy in head and neck cancer.\"\n\nExpert Opin Biol Ther. 2012 Dec;12(12):1669-78. doi: 10.1517\/14712598.201","author":{"name":"Oncolytics Biotech Inc.","url":"https:\/\/www.facebook.com\/194714477275831","facebook_wall_name":"Oncolytics Biotech Inc.","image":"https:\/\/graph.facebook.com\/194714477275831\/picture","id_on_source":"194714477275831"}}],"twitter":[{"url":"http:\/\/twitter.com\/Oncolytics\/statuses\/268744506529169411","license":"public","citation_ids":[1066793],"posted_on":"2012-11-14T15:57:38+00:00","author":{"name":"Oncolytics Biotech","url":"http:\/\/www.oncolyticsbiotech.com","image":"https:\/\/pbs.twimg.com\/profile_images\/674377785100529664\/SzXD2Zxz_normal.jpg","id_on_source":"Oncolytics","tweeter_id":"25760403","geo":{"lt":51.05011,"ln":-114.08529,"country":"CA"},"followers":830},"tweet_id":"268744506529169411"},{"url":"http:\/\/twitter.com\/donobo\/statuses\/268786075852476416","license":"public","citation_ids":[1066793],"posted_on":"2012-11-14T18:42:48+00:00","author":{"name":"MrD","image":"https:\/\/pbs.twimg.com\/profile_images\/511641161379753985\/og5TfamU_normal.jpeg","description":"Liberty, FreeSpeech, FreeMarkets, Science+Tech; Skeptic re CO2 responsible for climate change.  Stock Watch: $ONCYF $BLGO $REPCF","id_on_source":"donobo","tweeter_id":"34145536","geo":{"lt":null,"ln":null},"followers":422},"tweet_id":"268786075852476416"},{"url":"http:\/\/twitter.com\/Oncolytics\/statuses\/268743466564067328","license":"datasift","citation_ids":[1066793],"posted_on":"2012-11-14T15:53:30+00:00","author":{"name":"Oncolytics Biotech","url":"http:\/\/www.oncolyticsbiotech.com","image":"https:\/\/pbs.twimg.com\/profile_images\/674377785100529664\/SzXD2Zxz_normal.jpg","id_on_source":"Oncolytics","tweeter_id":"25760403","geo":{"lt":51.05011,"ln":-114.08529,"country":"CA"},"followers":830},"tweet_id":"268743466564067328"}]}}